13F reference period
Q2 2026
Security Snapshot
Immunocore Holdings plc - COMMON STOCK (IMCR) Institutional Ownership
CUSIP: 45258D105
13F Institutional Holders and Ownership History from Q1 2021 to Q3 2026
Institutions Reporting
135
Shares (Excl. Options)
52,107,162
Price
$31.75
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- IMCR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 52,107,162
- Total 13F value
- $1,653,706,045
- Portfolio coverage rank
- 0%
- Share change
- -402,938
- Value change
- -$5,980,190
- Number of holders
- 135
- Shares outstanding
- 48,249,417
- SEC-reported price per share
- $30.29
- Insider filing price
- $30.29
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- IMCR - Immunocore Holdings plc - COMMON STOCK is tracked under CUSIP 45258D105.
- 135 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 142 to 135 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,579,585,800 to $1,653,706,045.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 135 institutions filings for Q2 2026.
Security key
45258D105
13F reference period
Q2 2026
13F holders
135
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
IMCR full holder history
Immunocore Holdings plc SEC filings
Immunocore Holdings plc company facts
Immunocore Holdings plc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45258D105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
IMCR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 12% | +14% | $190,355,150 | +$26,410,388 | 5,959,773 | +16% | Wellington Management Group LLP | 30 Jun 2026 |
| Jallal Bahija | 8.2% | $135,513,072 | 4,493,139 | Jallal Bahija | 31 Dec 2024 | |||
| PRIMECAP MANAGEMENT CO/CA/ | 7.5% | +44% | $130,443,852 | +$38,165,393 | 3,772,234 | +41% | PRIMECAP MANAGEMENT CO/CA/ | 30 Jun 2025 |
| Bellevue Group AG | 5.6% | $101,607,853 | 2,796,803 | Bellevue Group AG | 20 Aug 2025 | |||
| TANG CAPITAL MANAGEMENT LLC | 5.2% | $94,662,520 | 2,605,608 | TANG CAPITAL MANAGEMENT, LLC | 17 Oct 2025 | |||
| T. Rowe Price Investment Management, Inc. | 3.7% | -38% | $60,417,704 | -$36,740,710 | 1,891,600 | -38% | T. Rowe Price Investment Management, Inc. | 31 Mar 2026 |
| Vestal Point Capital, LP | 3.5% | -33% | $57,492,000 | -$30,881,764 | 1,800,000 | -35% | Vestal Point Capital, LP | 30 Jun 2026 |
| FMR LLC | 3.6% | -58% | $52,613,094 | -$77,853,387 | 1,736,979 | -60% | FMR LLC | 30 Sep 2026 |
As of 30 Jun 2026, 135 institutional investors reported holding 52,107,162 shares of Immunocore Holdings plc - COMMON STOCK (IMCR). This represents 108% of the company’s total 48,249,417 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
91%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 12% | 5,721,945 | +22% | 0.03% | $181,671,753 |
| RTW INVESTMENTS, LP | 10% | 4,869,798 | 0% | 1.3% | $154,616,087 |
| FMR LLC | 8.9% | 4,307,246 | -11% | 0.01% | $136,755,061 |
| PRIMECAP MANAGEMENT CO/CA/ | 7.5% | 3,638,241 | -1.5% | 0.07% | $115,514,154 |
| Bellevue Group AG | 5.8% | 2,788,245 | -0.31% | 1.9% | $88,526,779 |
| TANG CAPITAL MANAGEMENT LLC | 5.5% | 2,649,368 | 0% | 3.8% | $84,117,434 |
| Vestal Point Capital, LP | 3.7% | 1,800,000 | -35% | 1.3% | $57,150,000 |
| TWO SIGMA INVESTMENTS, LP | 3.4% | 1,648,983 | +61% | 0.04% | $52,355,210 |
| MILLENNIUM MANAGEMENT LLC | 3.3% | 1,597,037 | +29% | 0.03% | $50,705,925 |
| ARMISTICE CAPITAL, LLC | 3% | 1,428,000 | +20% | 1.3% | $45,339,000 |
| Caligan Partners LP | 2.9% | 1,381,317 | 2.1% | $43,856,815 | |
| Kynam Capital Management, LP | 2.8% | 1,375,000 | +55% | 2.4% | $43,656,250 |
| BVF INC/IL | 2.7% | 1,294,463 | 0% | 1.1% | $41,099,200 |
| ACADIAN ASSET MANAGEMENT LLC | 2.5% | 1,209,894 | +141% | 0.05% | $38,391,000 |
| Trails Edge Capital Partners, LP | 2.2% | 1,063,234 | +56% | 5.4% | $33,757,680 |
| BlackRock, Inc. | 2.1% | 1,004,598 | +53% | 0% | $31,895,988 |
| Point72 Asset Management, L.P. | 2.1% | 990,280 | -10% | 0.05% | $31,441,390 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.7% | 831,068 | -9.6% | 0% | $26,387,000 |
| Jupiter Topco LLC | 1.5% | 709,022 | 0% | 0.01% | $22,504,358 |
| Logos Global Management LP | 1.2% | 600,000 | -60% | 0.82% | $19,050,000 |
| MARSHALL WACE, LLP | 1.2% | 590,941 | +228% | 0.02% | $18,762,377 |
| Hudson Bay Capital Management LP | 1.2% | 590,000 | -6.8% | 0.09% | $18,732,500 |
| CITADEL ADVISORS LLC | 1.2% | 566,761 | +146% | 0.01% | $17,994,662 |
| BRAIDWELL LP | 1.1% | 521,327 | 0.61% | $16,552,132 | |
| Jones Hill Capital LP | 1.1% | 512,856 | 3.5% | $16,283,178 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Headline period
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 203,502 | $6,164,076 | -$983,986 | $30.29 | 12 |
| 2026 Q2 | 52,107,162 | $1,653,706,045 | -$5,980,190 | $31.75 | 135 |
| 2026 Q1 | 52,393,743 | $1,579,585,800 | +$22,621,289 | $30.15 | 142 |
| 2025 Q4 | 51,535,356 | $1,787,298,986 | +$61,545,552 | $34.71 | 149 |
| 2025 Q3 | 49,181,489 | $1,786,701,511 | +$50,897,730 | $36.33 | 132 |
| 2025 Q2 | 47,759,431 | $1,498,675,257 | +$17,984,702 | $31.38 | 132 |
| 2025 Q1 | 47,287,653 | $1,402,998,400 | +$60,274,148 | $29.67 | 115 |
| 2024 Q4 | 45,410,647 | $1,339,563,608 | -$4,915,367 | $29.50 | 114 |
| 2024 Q3 | 45,295,985 | $1,411,075,539 | +$61,107,953 | $31.13 | 129 |
| 2024 Q2 | 43,068,701 | $1,459,854,294 | -$99,787,937 | $33.89 | 135 |
| 2024 Q1 | 41,233,666 | $2,679,814,816 | +$238,809,048 | $65.00 | 149 |
| 2023 Q4 | 37,514,062 | $2,563,043,022 | +$32,940,976 | $68.32 | 133 |
| 2023 Q3 | 36,945,020 | $1,917,423,501 | +$85,494,203 | $51.90 | 125 |
| 2023 Q2 | 35,306,138 | $2,115,733,529 | +$164,020,008 | $59.96 | 118 |
| 2023 Q1 | 32,689,414 | $1,614,615,481 | +$118,700,415 | $49.44 | 108 |
| 2022 Q4 | 30,264,419 | $1,727,211,273 | +$217,928,825 | $57.07 | 103 |
| 2022 Q3 | 26,369,515 | $1,237,624,033 | +$261,557,875 | $46.94 | 83 |
| 2022 Q2 | 21,039,614 | $784,510,369 | +$56,584,747 | $37.31 | 66 |
| 2022 Q1 | 19,740,280 | $590,138,252 | +$57,754,634 | $29.90 | 57 |
| 2021 Q4 | 17,133,052 | $586,618,000 | +$22,048,655 | $34.24 | 45 |
| 2021 Q3 | 16,654,128 | $617,381,000 | +$83,084,443 | $37.07 | 46 |
| 2021 Q2 | 13,805,464 | $538,109,000 | +$10,183,214 | $39.05 | 41 |
| 2021 Q1 | 14,110,965 | $597,836,000 | +$597,835,003 | $42.57 | 41 |